Qiagen anticipates growth in India, as it sets up subsidiary

Netherlands-based Qiagen (Nasdaq: QGEN), a provider of sample and assay technologies, has established an Indian India subsidiary, Qiagen India Pvt, and the beginning of direct sales in that country, with offices in New Delhi.

Until now, Qiagen products have been sold in India through distributor partnerships. The Dutch company has been active in India since 1995 and has developed numerous initiatives, partnerships and a strong network. The firm expects that this enhanced presence will further contribute to its position in the market, and is a further milestone in Qiagen’s strategy to expand its footprint in emerging, high-growth regions.

The Indian life sciences and biotech market is one of the fastest growing in the region. In 2010, the domestic market in India grew to revenues of $5 billion and is expected to approximately double by 2015. India's domestic in vitro diagnostics market is projected to grow at 15% annually in the next several years and to accelerate going forward due to government incentive programs and infrastructure investment.